$47.36
-0.40-0.84%
al cierre: -
$47.36
0.000.00%
After hour: 4:00 PM EDT
Comments
Loading...
Orientación y previsiones
Conmed emite una orientación sobre las ganancias por acción y los ingresos futuros, lo que ofrece a los inversores una idea de cuánto espera ganar la empresa en los próximos períodos.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
07/30/2025 | CNMD | Conmed | FY | 2025 | $4.40 | $4.55 | $4.41 | $1.36B | $1.38B | $1.36B | |
04/30/2025 | CNMD | Conmed | FY | 2025 | $4.45 | $4.60 | $4.34 | $1.35B | $1.38B | $1.36B | |
02/05/2025 | CNMD | Conmed | FY | 2025 | $4.25 | $4.40 | $4.74 | $1.34B | $1.37B | $1.40B | |
10/30/2024 | CNMD | Conmed | FY | 2024 | $4.00 | $4.05 | $3.99 | $1.30B | $1.30B | $1.31B | |
10/04/2024 | CNMD | Conmed | Q3 | 2024 | $0.98 | $1.00 | $0.99 | $315.00M | $318.00M | $318.67M | |
07/31/2024 | CNMD | Conmed | FY | 2024 | $3.95 | $4.02 | $4.29 | $1.30B | $1.31B | $1.33B | |
04/24/2024 | CNMD | Conmed | FY | 2024 | $4.25 | $4.35 | $4.33 | $1.33B | $1.35B | $1.35B | |
01/31/2024 | CNMD | Conmed | FY | 2024 | $4.30 | $4.40 | $4.40 | $1.34B | $1.36B | $1.36B | |
10/25/2023 | CNMD | Conmed | FY | 2023 | $3.45 | $3.55 | $3.48 | $1.24B | $1.26B | $1.25B | |
07/26/2023 | CNMD | Conmed | FY | 2023 | $3.40 | $3.55 | $3.42 | $1.23B | $1.26B | $1.23B | |
04/26/2023 | CNMD | Conmed | Q2 | 2023 | $0.77 | $0.82 | $0.79 | $300.00M | $310.00M | $301.46M | |
04/26/2023 | CNMD | Conmed | FY | 2023 | $3.30 | $3.50 | $3.32 | $1.21B | $1.25B | $1.19B | |
02/02/2023 | CNMD | Conmed | Q1 | 2023 | $0.58 | $0.63 | $0.61 | $262.00M | $272.00M | $268.73M | |
02/02/2023 | CNMD | Conmed | FY | 2023 | $3.20 | $3.45 | $3.37 | $1.17B | $1.22B | $1.21B | |
11/15/2022 | CNMD | Conmed | FY | 2023 | $3.20 | $3.50 | $3.39 | $1.17B | $1.23B | $1.21B | |
10/26/2022 | CNMD | Conmed | FY | 2022 | $3.21 | $3.28 | $3.28 | $1.10B | $1.11B | $1.11B | |
10/26/2022 | CNMD | Conmed | Q4 | 2022 | $0.98 | $1.05 | $1.06 | $305.00M | $320.00M | $313.65M | |
07/27/2022 | CNMD | Conmed | Q3 | 2022 | $0.78 | $0.84 | $0.92 | $275.00M | $290.00M | $284.96M | |
07/27/2022 | CNMD | Conmed | FY | 2022 | $3.40 | $3.55 | $3.50 | $1.09B | $1.14B | $1.12B | |
05/04/2022 | CNMD | Conmed | FY | 2022 | $3.50 | $3.65 | $3.69 | $1.10B | $1.15B | $1.09B | |
01/26/2022 | CNMD | Conmed | FY | 2022 | $3.60 | $3.85 | $3.74 | $1.07B | $1.13B | $1.11B | |
10/27/2021 | CNMD | Conmed | FY | 2021 | $3.18 | $3.23 | $3.19 | $1.01B | $1.01B | $1.03B | |
07/28/2021 | CNMD | Conmed | FY | 2021 | $3.15 | $3.25 | $3.15 | $1.01B | $1.03B | $1.02B | |
04/28/2021 | CNMD | Conmed | FY | 2021 | $3.05 | $3.20 | $2.94 | $1.00B | $1.03B | $996.57M |
PREGUNTAS FRECUENTES
¿Cuál es la orientación más reciente de Conmed (CNMD)?
La orientación más reciente para Conmed (CNMD) se informó el julio 30, 2025 para el año completo 2025. La empresa proporcionó una guía de ganancias por acción en el rango de $4.40 a $4.55, en comparación con el EPS estimado de $4.41. Además, Conmed pronosticó ingresos entre $1.36B y $1.38B para el trimestre.
Explora orientación y previsión sobre todos los valores.